Selected Publications
Etherington MS, Geller DA: Minimally invasive vs. open liver resections for hepatocellular carcinoma and colorectal cancer liver metastases Surgery: Evidence Based Practice, 2d Edition : 2024 (in press).
Etherington MS, Handzel R, Ongchin M, Choudry MH, Tohme ST, Paniccia A, Lee KK, Zureikat A, Geller DA: Remnant completion cholecystectomy is on the rise: Don't three-putt it HPB (Oxford) 26 (8): 1072-1074,2024.
Etherington MS, O’Sullivan R, Paniccia A, Brand RE, McGrath K, Slivka A, Singhi AD, Zureikat AH: Genomic profiling of pancreatic neuroendocrine tumors defines clinically relevant prognostic markers HPB 26 (2): S613-S614,2024.
Etherington MS, Handzel R, Ongchin M, Choudry MH, Tohme ST, Paniccia A, Lee KK, Zureikat A, Geller DA: Remnant cholecystectomy: A twenty year institutional experience HPB 26 (2): S645,2024.
Wach MM, Washburn LA, Alvikas J, Qu LT, Zhang M, Etherington MS, Rieser C, Haykal T, Pingpank JF, Zureikat AH, Geller DA, Hoehn RS, Tohme S: Combined hepatic resection and ablation for high burden of colorectal liver metastases demonstrates safety and durable survival HPB (Oxford) 26 (3): 362-369,2024.
Lo WM, Dogeas E, Etherington MS, Ferrone C, Nebbia M, Cleary S, Pery R, Steel JL, Tohme ST, Geller DA: Long-term overall survival in patients undergoing liver resection for metastatic anal squamous cell carcinoma Journal of Surgical Oncology 129 (3): 568-573,2024.
Etherington MS, Hanna AN, Medina BD, Liu M, Tieniber AD, Kwak HV, Tardy KJ, Levin L, Do KJ, Rossi F, Zeng S, DeMatteo RP: Tyrosine kinase inhibition activates intratumoral gamma delta T cells in gastrointestinal stromal tumor Cancer Immunology Research 12 (1): 107-119,2024.
Etherington MS, Tohme ST, Ongchin M, Geller DA: Remnant completion cholecystectomy at a single institution over 20 years: Don't three-putt it Journal of the American College of Surgeons 23 (5 Suppl 1): S301-S302,2023.
Tieniber AD, Rossi F, Hanna AN, Liu M, Etherington MS, Loo JK, Param N, Zeng S, Do K, Wang L, DeMatteo RP: Multiple intratumoral sources of kit ligand promote gastrointestinal stromal tumor Oncogene 42 (34): 2578-2588,2023.
Rossi F, Liu M, Tieniber A, Etherington MS, Hanna A, Vitiello GA, Param NJ, Do K, Wang L, Antonescu CR, Zeng S, Zhang JQ, DeMatteo RP: Myosin light-chain kinase inhibition potentiates the antitumor effects of avapritinib in PDGFRA D842V-mutant gastrointestinal stromal tumor Clinical Cancer Research 29 (11): 2144-2157,2023.
Academic Contact Information
Division of Endocrine & Oncologic Surgery
Penn Medicine Washington Square
800 Walnut Street, 20th Floor
Philadelphia,
PA
19107
Phone: 215-614-1963
Patient appointments: 800-789-7366